Results 221 to 230 of about 182,106 (353)

Combination therapy in preclinical studies and clinical trials: Evidence, gaps and the path ahead

British Journal of Pharmacology, EarlyView.
Shanshan Li, Leonie Dreher, A. H. Jan Danser, Ulrich O. Wenzel   +3 more
wiley   +1 more source

Sustained metabolic improvements in a remotely delivered ketogenic nutrition programme for veterans with type 2 diabetes: A 3‐year observational study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim To evaluate the long‐term effectiveness and safety of a remote, medically supervised ketogenic nutrition therapy intervention for Veterans with type 2 diabetes (T2D). Materials and Methods This retrospective observational analysis examined de‐identified medical records of Veterans with T2D who engaged in a remote continuous care ...
Rebecca N. Adams, Shaminie J. Athinarayanan, Alison R. Zoller, Amy L. McKenzie, Robert E. Ratner   +4 more
wiley   +1 more source

Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy? [PDF]

Antibodies (Basel)
Lee HS, Wu HHL, Ponnusamy A, Alderson H, Chinnadurai R.   +4 more
europepmc   +1 more source

Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy [PDF]

, 1999
Esteban Wisnivesky Rocca Rivarola, Miguel Moysés Neto, Márcio Dantas, C.G. da-Silva, Rildo Aparecido Volpini, Terezila Machado Coimbra   +5 more
openalex   +1 more source

Impact of baseline alanine aminotransferase levels on the efficacy of dapagliflozin and sitagliptin: Latent class analysis from the DIVERSITY‐CVR study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Dapagliflozin and sitagliptin exhibit variable efficacy in managing type 2 diabetes mellitus (T2DM), with outcomes influenced by factors like body mass index (BMI). However, biochemical determinants of treatment response remain poorly defined.
Kohei Mochizuki, Ayako Fuchigami, Takahisa Hirose, Hiroshi Uchino   +3 more
wiley   +1 more source

Diabetes mellitus and its complications in Japan. The dysfunction of mesangial cells on pathogenesis of diabetic nephropathy.

, 1991
Yukio Shigeta, Ryuichi Kikkawa
openalex   +2 more sources

Progression of renal failure in diabetic nephropathy [PDF]

, 1998
Carmelita Marcantoni
openalex   +1 more source

Potential benefits of hybrid closed‐loop systems for managing moderate‐ to high‐risk individuals with type 1 diabetes during Ramadan fasting

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim We evaluated whether using hybrid closed‐loop systems (HCL) provides a safer, more effective fasting experience compared with multiple daily injections with continuous glucose monitoring (MDI + CGM) for people with T1D at moderate‐to‐high risk in a real‐world setting.
Abdullah M. Alguwaihes, Metib S. Alotaibi, Hamid Alqumaidi, Mohammed A. Batais, Abdullah A. Alrasheed, Layla N. Alnasser, Janaka Karalliedde, Sufyan Hussain   +7 more
wiley   +1 more source

Mapping the future: bibliometric insights into ferroptosis and diabetic nephropathy. [PDF]

Front Physiol
Wei T, Qin Y, Lin X, Wang X, Chen S, Chen X, Yan N, Wei X, Zhang Z, Wei B.   +9 more
europepmc   +1 more source

Cellular events in the evolution of experimental diabetic nephropathy

, 1995
Bessie A. Young, Richard J. Johnson, Charles E. Alpers, Eudora Eng, Katherine Gordon, Jürgen Floege, William G. Couser, W. Seidel   +7 more
openalex   +1 more source